Androgens in Women: Hormone-Modulating Therapies for Androgen-Mediated Cutaneous Disorders

    Sarah Azarchi, Amanda Bienenfeld, Kristen Lo Sicco, Shari Marchbein, Jerry Shapiro, Arielle R. Nagler
    Image of study
    TLDR Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.
    The document from June 2019 reviews hormone-modulating therapies for androgen-mediated cutaneous disorders (AMCDs) in women, such as acne, hirsutism, and female pattern hair loss (FPHL). It discusses the efficacy, safety, and mechanisms of various treatments, including combined oral contraceptives (COCs), spironolactone, finasteride, dutasteride, and flutamide. COCs are FDA-approved for acne and are as effective as antibiotics after 6 months, while spironolactone is used off-label for acne and hirsutism but lacks high-quality evidence. Flutamide is effective for hirsutism but carries a risk of hepatotoxicity and is not recommended as first-line therapy. For FPHL, minoxidil is the only FDA-approved treatment, with other drugs used off-label. The document notes that flutamide is the most effective for hirsutism but not first-line due to hepatotoxicity, and while dutasteride is superior to finasteride in men, it lacks RCTs in women for FPHL. The importance of a 6-month trial, periodic monitoring, and contraception for women of child-bearing age on these treatments is emphasized, along with the need for more rigorous studies to evaluate these therapies for AMCDs.
    Discuss this study in the Community →

    Research cited in this study

    53 / 53 results

    Related Community Posts Join

    6 / 1000+ results

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  122 upvotes 1 year ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  62 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

      community Well here I am 3-4 years later.

      in Update  56 upvotes 1 year ago
      The conversation is about someone who has been taking finasteride for hair loss without success, considering switching to dutasteride or giving up treatment. Suggestions include trying dutasteride, microneedling, infrared therapy, multivitamins, and high-concentration topical solutions combining finasteride and dutasteride.

      community DHT Isn't (Directly) Important

      in Research/Science  93 upvotes 3 days ago
      Finasteride's potential side effects, especially sexual dysfunction, are discussed, with emphasis on hormonal balance between testosterone and estradiol. Users share experiences with finasteride, minoxidil, and dutasteride, highlighting the variability in side effects and the influence of mindset and lifestyle.

    Similar Research

    5 / 1000+ results